Financials

  • Market Capitalization 1.47 B
  • Employee 975
  • Founded 2007
  • CEO N/A
  • Website www.iovance.com
  • Headquarter Delaware, United States
  • FIGI BBG000FTLBV7
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-2.5
売上高対価格比率
0

Iovance Biotherapeutics Inc

Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer.

ニュース